| Stage | XPEL | % of rev | OPXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $143M | 100.00% | $10M | 100.00% | XPEL ×14.70 |
| Gross profit | $63M | 44.14% | $3M | 34.18% | XPEL +10.0pp |
| Operating income | $23M | 16.23% | $1M | 14.30% | XPEL +1.9pp |
| Pre-tax income | $23M | 16.33% | $1M | 14.59% | XPEL +1.7pp |
| Net income | $18M | 12.79% | $1M | 13.16% | OPXS +0.4pp |
| Stage | XPEL | OPXS | Gap · A − B |
|---|---|---|---|
| Revenue | $143M100.00% | $10M100.00% | XPEL ×14.70 |
| Gross profit | 44.14%$63M | 34.18%$3M | XPEL +10.0pp |
| Operating income | 16.23%$23M | 14.30%$1M | XPEL +1.9pp |
| Pre-tax income | 16.33%$23M | 14.59%$1M | XPEL +1.7pp |
| Net income |
| 12.79%$18M |
| 13.16%$1M |
| OPXS +0.4pp |
No disclosed counterparties: XPEL, OPXS.